Journal of Organic Chemistry p. 3442 - 3447 (1982)
Update date:2022-08-11
Topics:
Smith, Amos B.
Malamas, Michael S.
This, a full account, discloses an efficient, convergent synthesis of two novel analogues of the macrocyclic antitumor diterpene jatrophone (1).We term these analogues cis- and trans-normethyljatropholactone (2 and 3, respectively).Our approach in each case begins with the bis(trimethylsilyloxy) ketone 7 and the requisite acetylenic or trans ester-aldehyde, 8 or 12a.Application of our previously developed 3(2H)-furanone synthetic protocol consisting of aldol condensation of the lithium enolate derived from 7 with the respective ester-aldehydes 8 or 12a, followed byoxidation (Collins reagent) and acid-catalyzed cyclization-dehydration, affords spirofuranone 6c and 14c, respectively, in 52percent and 45percent overall yields.Sodium borohydride reduction, ester hydrolysis, and closure of the macrolide by employing the conditions of Mukaiyama (i.e., 1-methyl-2-chloropyridinium iodide-/Et3N/CH3CN) in the case of spirofuranone 14a leads directly to trans-normethyljatropholactone (3), while completion of cis-normethyljatropholactone (2) requires first semihydrogenation; the latter was accomplished by employing PdSO4 in pyridine as the catalyst.The overall yields of 2 and 3, based on 7, were 23percent and 21percent, respectively.
View Morewebsite:http://www.josunpharma.com
Contact:+86-311-80715268 80766839
Address:No.39, Zhaiying Street, Shijaizhuang,Hebei,China
Arshine Pharmaceutical Co., Limited
website:http://www.cnarshine.com
Contact:0731-88503671
Address:Room 1109.Block C3, Lugu Enterprise Plaza,No.27 Wenxuan Road,Changsha National Hi-Tech Industrial Development Zone,Hunan ,P.R.China
Changzhou Anyi Biochem Co., Ltd.
Contact:+86-519-88836158
Address:no,51 caoda
Hangzhou Gangjin Chemical Co.,Ltd.
Contact:+86-571-85109780
Address:707 Zhejiang Minhang Bldg., No.290 Zhongshan North Road, Hangzhou 310003, China
Contact:+86-29-88710656
Address:South Tai bai Road, High Tech Development Zone, Xi'an China
Doi:10.1002/cbdv.200800210
(2009)Doi:10.1002/anie.201509602
(2016)Doi:10.1246/cl.1997.827
(1997)Doi:10.1007/BF00579758
()Doi:10.1021/ja061942s
(2006)Doi:10.1021/jp9718919
(1998)